STAB1 and neoplasm: STAB1 levels were not significantly different between patients who received three versus six cycles of NACT or between BRCA mutated and HRD (BRCAm/HRD) tumours versus BRCA wild-type and non-HRD tumours (BRCA-WT) (Supplementary Fig. S1G).